Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan for Pulmonary Hypertension in Diastolic Heart Failure
NCT00840463Phase 4Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ambrisentan in pulmonary hypertension (PH), sponsored by UT Southwestern Medical Center. Started Jan 2009; status: terminated.
02
Drugs
ambrisentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00840463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840463.